115 related articles for article (PubMed ID: 18790766)
1. AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.
Nie B; Shen Z; Wen JB; Wong OG; Hsueh WD; Huo LF; Kung HF; Jiang B; Lin MC
Mol Cancer Ther; 2008 Sep; 7(9):2855-65. PubMed ID: 18790766
[TBL] [Abstract][Full Text] [Related]
2. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
[TBL] [Abstract][Full Text] [Related]
3. The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.
Shen Z; Yang ZF; Gao Y; Li JC; Chen HX; Liu CC; Poon RT; Fan ST; Luk JM; Sze KH; Li TP; Gan RB; He ML; Kung HF; Lin MC
Cancer Res; 2008 Jan; 68(2):404-14. PubMed ID: 18199534
[TBL] [Abstract][Full Text] [Related]
4. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
5. Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
Sun P; Liu Z
Biochem Biophys Res Commun; 2019 Jan; 508(1):130-137. PubMed ID: 30471863
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
Jie JZ; Wang JW; Qu JG; Hung T
World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.
Chang S; Yang J; Chen W; Xie Y; Sheng W
Mol Biol Rep; 2011 Jan; 38(1):395-401. PubMed ID: 20354907
[TBL] [Abstract][Full Text] [Related]
8. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
Gao X; Jiang P; Zhang Q; Liu Q; Jiang S; Liu L; Guo M; Cheng Q; Zheng J; Yao H
J Exp Clin Cancer Res; 2019 Aug; 38(1):362. PubMed ID: 31426831
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.
Tu SP; Cui JT; Liston P; Huajiang X; Xu R; Lin MC; Zhu YB; Zou B; Ng SS; Jiang SH; Xia HH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC
Gastroenterology; 2005 Feb; 128(2):361-75. PubMed ID: 15685548
[TBL] [Abstract][Full Text] [Related]
10. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor.
Takimoto R; Kato J; Terui T; Takada K; Kuroiwa G; Wu J; Ohnuma H; Takahari D; Kobune M; Sato Y; Takayama T; Matsunaga T; Niitsu Y
Cancer Biol Ther; 2005 Apr; 4(4):421-8. PubMed ID: 15846102
[TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
[TBL] [Abstract][Full Text] [Related]
14. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
15. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
17. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.
Wang X; Su C; Cao H; Li K; Chen J; Jiang L; Zhang Q; Wu X; Jia X; Liu Y; Wang W; Liu X; Wu M; Qian Q
Mol Cancer Ther; 2008 Jun; 7(6):1598-603. PubMed ID: 18566230
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
Xue Z; Sun PH; Zhu LM; Jiang SH; Qiao MM; Chi AL; Tu SP
Oncol Rep; 2011 Apr; 25(4):1039-46. PubMed ID: 21279308
[TBL] [Abstract][Full Text] [Related]
19. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
20. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.
Zhang H; Zhou X; Xu C; Yang J; Xiang J; Tao M; Xie Y
Cancer Gene Ther; 2016 Jan; 23(1):13-23. PubMed ID: 26564429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]